nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

01.08.2014 | Original Paper

Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia

verfasst von: Adesanmi Akinsulore, Olutayo O. Aloba, B. M. Mapayi, I. O. Oloniniyi, F. O. Fatoye, R. O. A. Makanjuola

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Quality of life (QOL) in patients with schizophrenia is influenced by various factors such as depressive symptoms. This study assessed the relationship between depressive symptoms and QOL in outpatients with schizophrenia in Nigeria and evaluated the associated socio-demographic and clinical factors.

Methods

One hundred patients with 10th edition of the International Classification of Diseases diagnosis of schizophrenia participated in this study. Socio-demographic and clinical factors such as depression were assessed with Zung Self-rating Depression Scale and symptoms of schizophrenia with the Positive and Negative Syndrome Scale of schizophrenia (PANSS). The level of functioning was assessed with the Global Assessment of Functioning Scale. QOL was assessed using the brief version of the World Health Organisation Quality of Life Scale.

Results

There were 27 (27.0 %) patients with depression. The depressed patients reported significant lower scores in all QOL domains when compared with the non-depressed group. All QOL domains were significantly negatively correlated with the total PANSS and all its subscales (except for psychological domain with total PANSS and social relationship and environmental domains with PANSS positive). Severity of depressive symptoms was significantly negatively correlated with all QOL domains. Functioning was significantly positively correlated with all QOL domains except in the environmental domain. Multiple regression analysis showed that depressive symptoms predicted all QOL domains except the social relationship domain while negative symptoms predicted social relationship and environmental domains.

Conclusion

Depression is a common occurrence during the course of schizophrenia. Depressive and negative symptoms have a significant impact on the QOL of patients with schizophrenia.

Adewuya AO, Makanuola ROA (2009) Subjective quality of life of Nigerian schizophrenia patients: socio-demographic and clinical correlates. Acta Psychiatr Scand 120:160–164PubMedCrossRef

Carpiniello B, Lai GL, Pariante CM, Carta MG, Rudas H (1997) Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed outpatients. Acta Psychiatr Scand 96:235–241PubMedCrossRef

Green CA, Fenn DS, Moussaoui D, Kadri N, Hoffman WF (2001) Quality of life in treated and never-treated schizophrenic patients. Acta Psychiatr Scand 103:131–142PubMedCrossRef

Chemerinski E, Bowie C, Anderson H, Harvey PD (2008) Depression in schizophrenia: methodological Artifact or distinct feature of the illness? J Neuropsychiatr Clin Neurosci 20:431–440CrossRef

Cohen C, Talavera N (2000) Functional impairment in older schizophrenic persons: toward a conceptual model. Am J Geriatr Psychiatry 8:237–244PubMedCrossRef

Reine G, Lancon C, Di Tucci S, Sapin C, Auquier P (2003) Depression and subjective quality of life in chronic phase schizophrenic patients. Acta Psychiatr Scand 108(4):297–303PubMedCrossRef

Sim K, Chua TH, Chan YH, Mahendran R, Chong SA (2006) Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study. J Psychiatry Res 40:656–663CrossRef

Tollefson GD, Andersen SW, Tran PV (1999) The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone. Biol Psychiatry 46(3):365–373PubMedCrossRef

Tomotake M, Kaneda Y, Iga J, Kinouchi S, Tayoshi S, Motoki I, Sumitani S, Yamauchi K, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T (2009) Subjective and objective Measure of quality of life have different predictors of people with schizophrenia. Psychol Rep 99(2):477–487CrossRef

10.

Aki H, Tomotake M, Kaneda Y, Iga J, Kinouchi S, Shibuya-Tayoshi S, Tayoshi SY, Motoki I, Moriguchi K, Sumitani S, Yamauchi K, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T (2008) Subjective and objective quality of life, levels of life skills and their clinical determinants in outpatients with schizophrenia. Psychiatry Res 158(1):19–25PubMedCrossRef

11.

Siris SG, Addington D, Azorin JM, Falloon IR, Gerlach J, Hirsch SR (2001) Depression in schizophrenia: recognition and management in the USA. Schizophr Res 47:185–197PubMedCrossRef

12.

Murali T, Kumar Ravi S (2008) Symptoms of depression in schizophrenia. Indian J Med Res 127:516–518PubMed

13.

Shrivastrara A, Johnson M, Terestra K, Stitt L, Shah N (2012) Atypical antipsychotics usage in long term follow-up of first episode schizophrenia. Indian J Psychiatry 54(3):248–252CrossRef

14.

Hirsch SR, Jolley A, Barnes T (1990) Are depressive symptoms part of the schizophrenic syndrome? In: Delisi LE (ed) Depression in schizophrenia. American Psychiatric Press, Washington D.C., pp 22–37

15.

Hafner H, Maurer K, Trendler G, der an Heiden W, Schmidt M, Konnecke R (2005) Schizophrenia and depression: challenging the paradigm of two separate diseases—a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 77(3):11–24PubMedCrossRef

16.

Mauri MC, Moliterno D, Rossattini M, Colasanti A (2008) Depression in schizophrenia: comparison of first and second generation antipsychotic drugs. Schizophr Res 99:7–12PubMedCrossRef

17.

Bressan RA, Chaves AC, Pilowsky LS, Shirakawa I, Mari JJ (2003) Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatr Res 117:47–56CrossRef

18.

Siris SG (2000) Depression in schizophrenia: perspective in the Era of “Atypical” antipsychotic agents. Am J Psychiatry 157:1379–1389PubMedCrossRef

19.

Banerjee A (2012) Cross-cultural variance of schizophrenia in symptoms, diagnosis and treatment. Georget Undergrad J Health Sci 6(2):18–24

20.

Olusina AK, Ohaeri JU (2003) Subjective quality of life of recently discharged Nigerian psychiatric patients. Soc Psychiatry Psychiatr Epidemiol 38(12):707–714PubMedCrossRef

21.

Makanjuola AB, Adeponle AB, Obembe AO (2005) Quality of life in patients with schizophrenia in Nigeria. Niger Med Pract 2:36–42

22.

World Health Organisation (1992) International Classification of Diseases, 10th edn. World Health Organisation, Geneva

23.

Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Amorim P, Janavs J, Weiller E et al. (1998) The Mini International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry 59:22–33PubMed

24.

Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64(6):663–667PubMedCrossRef

25.

Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho B (2010) Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 67(3):255–262PubMedCentralPubMedCrossRef

26.

Kay SR, Fyszbern A, Opler LA (1987) The Positive and Negative Syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMedCrossRef

27.

Zung WWK (1965) A self rating depression scale. Arch Gen Psychiatry 12:63–70PubMedCrossRef

28.

Jegede RO (1979) Psychometric characteristics of Yoruba version of Zung’s self rating depression scale and self rating anxiety scale. Afr J Med Sci 8:133–137

29.

Fatoye FO, Adeyemi AB, Oladimeji BY (2004) Emotional distress and its correlates among Nigerian Women in late pregnancy. J Obstet Gynaecol 24(5):504–509PubMedCrossRef

30.

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DC

31.

WHOQOL Group (1998) The WHO Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585CrossRef

32.

Cohen A, Patel V, Thara R, Gureje O (2008) Questioning an axiom: better prognosis for schizophrenia in the developing world. Schizophr Bull 34(2):229–244PubMedCentralPubMedCrossRef

33.

Srinivasan TN, Tirupati S (2005) Relationship between cognition and work functioning among patients with schizophrenia in an urban area in India. Psychiatr Serv 56:67–74CrossRef

34.

Lieberman JA (2007) Effectiveness of antipsychotic drugs in patient with chronic schizophrenia: efficacy, safety and cost outcome of CATIE and other trials. J Clin Psychiatry 68:e04PubMedCrossRef

35.

Humberstone V, Wheeler A, Lambert T (2004) An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand. Aust N Z J Psychiatry 38:240–245PubMedCrossRef

36.

Misawa F, Shimizu K, Fujii Y, Miyata R, Koshiishi F, Kobayashi M et al. (2011) Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study. BMC Psychiatry 11:118PubMedCentralPubMedCrossRef

37.

Chemerinski E, Bowie C, Anderson H, Harvey PD (2008) Depression in schizophrenia: methodological artifact or distinct feature of the illness? J Neuropsychiatry Clin Neurosc 20:431–440CrossRef

38.

Avgustin B (2009) Depression in schizophrenia—literature overview. Psychiatr Danub 21(1):93–97PubMed

39.

Liddle PF, Barnes TRE, Curson DA, Patel M (1993) Depression and the experience of psychological deficits in schizophrenia. Acta Psychaitr Scandinavica 88:243–247CrossRef

40.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS (2007) Quality of life of Chinese schizophrenia outpatients in Hong Kong: relationship to sociodemographic factors and symptomatology. Aust N Z J Psychiatry 41:442–449PubMedCrossRef

41.

Wittorf A, Wiedermann G, Buchkremer G, Klingberg S (2008) Prediction of community outcome of schizophrenia 1 year after discharge from inpatient treatment. Eur Arch Psychiatry Clin Neurosci 258(1):48–58PubMedCrossRef

42.

Erol A, Kedes Unal E, Tunc Aydin E, Mete L (2009) Predictors of social functioning in schizophrenia. Turk Psikiyatri Dergisi 24:313–321

43.

Zemishlany Z, Weizman A (2008) The impact of mental illness on sexual dysfunction. In: Balon R (ed) Sexual dysfunction the brain-body connection. Advance in Psychosomatic Medicine 29:89–106

Titel: Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia
verfasst von: Adesanmi Akinsulore
Olutayo O. Aloba
B. M. Mapayi
I. O. Oloniniyi
F. O. Fatoye
R. O. A. Makanjuola
Publikationsdatum: 01.08.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 8/2014
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-014-0838-8

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia